Skip to content

Comparison of the effects of erector spinae plane block and iliac fascia block on postoperative pain and quality of recovery in elderly hip arthroplasty patients

Comparison of the effects of erector spinae plane block and iliac fascia block on postoperative pain and quality of recovery in elderly hip arthroplasty patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076385
Enrollment
Unknown
Registered
2023-10-07
Start date
2023-10-10
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip arthroplasty

Interventions

Group ESPB:At the level of the 4th lumbar vertebra, 15 ml of 0.2% ropivacaine was injected between the erector spinae muscle and the transverse process, and then 15 ml of 0.2% ropivacaine was injected
Group FIB:30 ml of 0.2% ropivacaine injected into the iliac fascial space above the inguinal ligament

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Age =60 years old; Preoperative ASA classification ?~?; elective unilateral hip replacement surgery; general anesthesia; patients or family members aware of the study and signing an informed consent form;

Exclusion criteria

Exclusion criteria: Revision hip arthroplasty; refusal to perform nerve; contraindications to puncture such as coagulation dysfunction, allergy to local anesthetics, skin infection at the site of puncture, systemic infection, etc.; presence of serious nerve injury in the limb on the side of the block; long-term use of opioids; poor comprehension, comorbid psychiatric illnesses, etc., making it difficult to complete the scoring and cooperate with the procedure; people with major concomitant heart, brain, liver, kidney, and other diseases; the existence of peripheral neurological disorders, chronic pain syndromes, and diseases associated with arterial venous thrombosis.

Design outcomes

Primary

MeasureTime frame
Postoperative resting and movement pain score (NRS);Postoperative 24h Quality of Recovery Score (QoR-15);Postoperative analgesic dosage;

Secondary

MeasureTime frame
Number of postoperative analgesic pump presses;Postoperative adverse events;Postoperative satisfaction score;Modified Bromage score of the lower limbs at 6h postoperatively;Time to first postoperative bed activity;Pain score (NRS) at rest and during exercise at 3 months postoperatively;Ability-to-Daily-Life Score (ADL) at 3 months postoperatively;Length of hospital stay;

Countries

China

Contacts

Public ContactChen Wei

The First Affiliated Hospital of Chongqing Medical University

261033409@qq.com+86 136 2973 1880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026